Search
for

    Sort by

    Research 91–120 of 1000+

    1. Topical imiquimod—Be aware of the unexpected Journal of The American Academy of Dermatology · 2016 · 3 citations
    2. Hirsutism: from Brazil to a place near you Expert Opinion on Pharmacotherapy · 2010 · 3 citations
    3. The Evaluation and Treatment of Hirsute Women Women's health · 2005 · 3 citations
    4. Reversal of andro-genetic alopecia in a male. A spironolactone effect? Acta dermato-venereologica · 1990 · 3 citations
    5. Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia Obstetrics & Gynecology · 2023 · 2 citations
    6. Hyperandrogenism: Acne and Hirsutism 2017 · 2 citations
    7. Recognizing polycystic ovary syndrome in the primary care setting The Nurse practitioner · 2009 · 2 citations
    8. Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study. PubMed · 1986 · 2 citations
    9. Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome Baylor University Medical Center Proceedings · 2025 · 1 citations
    10. Hyperandrogenism: Acne and Hirsutism 2023 · 1 citations
    11. Androgenetic Alopecia in Transgender and Gender Diverse Populations: A Review of Therapeutics Journal of The American Academy of Dermatology · 2021 · 1 citations
    12. Is spironolactone better than finasteride for symptoms of hirsutism in transgender women? Evidence-Based Practice · 2019 · 1 citations
    13. British Cosmetic Dermatology Group British Journal of Dermatology · 2015 · 1 citations
    14. Hyperandrogenism: Acne and Hirsutism 2015 · 1 citations
    15. Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K. British Journal of Dermatology · 2012 · 1 citations
    16. Topical Finasteride Therapy in Hirsutism Endocrine Practice · 2001 · 1 citations
    17. Hormonal Therapy for Acne Journal of Cutaneous Medicine and Surgery · 1996 · 1 citations
    18. Pharmacology of Anti-androgens in the Skin Handbook of experimental pharmacology · 1989 · 1 citations
    19. Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making Journal of Ovarian Research · 2026
    20. Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation Journal of Cutaneous and Aesthetic Surgery · 2026
    21. Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis Frontiers in Medicine · 2026
    22. Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies Quality in Sport · 2026
    23. Age-related downregulation of dihydrotestosterone-inactivating enzymes in human scalp sebaceous glands Inflammation and Regeneration · 2026
    24. Age-related downregulation of dihydrotestosterone-inactivating enzymes in human scalp sebaceous glands Figshare · 2026
    25. Age-related downregulation of dihydrotestosterone-inactivating enzymes in human scalp sebaceous glands Figshare · 2026
    26. Quality of Life in Polycystic Ovary Syndrome after Anti-Androgen Therapy Using PCOSQOL-47 and PCOSQOL-42 Endocrine Metabolic & Immune Disorders - Drug Targets · 2026
    27. Prescribing Habits for Androgenetic Alopecia among Dermatologists in Spain in 2024: A Cross-Sectional Study Actas Dermo-Sifiliográficas · 2026
    28. Beyond Boundaries: The Transformative Potential of Spironolactone in Female Pattern Hair Loss Zenodo (CERN European Organization for Nuclear Research) · 2026
    29. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments American Journal of Clinical Dermatology · 2026
    30. Alopecia Feminina De Origem Endócrina: Abordagem Integrativa Editora Pasteur eBooks · 2026